Topics

FDA Requests Belviq Be Pulled From The US Market Due To Cancer Risk

13:43 EST 13 Feb 2020 | SCRIP

The agency requested the weight loss pill be voluntarily recalled by Eisai, the death knell for a trio of obesity...

      

Related Stories

 

Original Article: FDA Requests Belviq Be Pulled From The US Market Due To Cancer Risk

NEXT ARTICLE

More From BioPortfolio on "FDA Requests Belviq Be Pulled From The US Market Due To Cancer Risk"

Quick Search

Relevant Topic

Obesity
Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dictionary of Medicine). It is becoming increasing common i...